鉄欠乏性貧血治療薬の世界市場2019

【英語タイトル】Global Iron Deficiency Anemia Drug Market Research Report 2019

QYResearchが出版した調査資料(QYR09GE06)・商品コード:QYR09GE06
・発行会社(調査会社):QYResearch
・発行日:2019年5月
・ページ数:約130
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,900 ⇒換算¥319,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD5,800 ⇒換算¥638,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

The global Iron Deficiency Anemia Drug market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.

This report focuses on Iron Deficiency Anemia Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Iron Deficiency Anemia Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At the company level, this report focuses on the sales, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
 AMAG Pharmaceuticals, Inc
 Meda Consumer Healthcare Inc
 American Regent, Inc
 GSK
 Avion Pharmaceuticals, LLC
 Bausch Health Companies Inc
 Colorado Biolabs, Inc
 Prestige Consumer Healthcare Inc
 Keryx Biopharmaceuticals, Inc
 Daiichi Sankyo, Inc.
 DSE Healthcare Solutions, LLC

Segment by Regions
 North America
 Europe
 China
 Japan
 Rest of World

Segment by Type
 Prescription Drugs
 Over-the-Counter (OTC)

Segment by Application
 Child
 Adult
 Elderly

【レポートの目次】

1 Iron Deficiency Anemia Drug Market Overview
1.1 Product Overview and Scope of Iron Deficiency Anemia Drug
1.2 Iron Deficiency Anemia Drug Segment by Types
1.2.1 Global Iron Deficiency Anemia Drug Sales Growth Rate Comparison by Types (2014-2025)
1.2.2 Prescription Drugs
1.2.3 Over-the-Counter (OTC)
1.3 Iron Deficiency Anemia Drug Segment by Applications
1.3.1 Global Iron Deficiency Anemia Drug Sales Comparison by Applications (2014-2025)
1.3.2 Child
1.3.3 Adult
1.3.4 Elderly
1.4 Global Iron Deficiency Anemia Drug Market by Regions
1.4.1 Global Iron Deficiency Anemia Drug Market Size by Regions
1.4.2 North America Iron Deficiency Anemia Drug Status and Prospect (2014-2025)
1.4.3 Europe Iron Deficiency Anemia Drug Status and Prospect (2014-2025)
1.4.4 China Iron Deficiency Anemia Drug Status and Prospect (2014-2025)
1.4.5 Japan Iron Deficiency Anemia Drug Status and Prospect (2014-2025)
1.5 Global Iron Deficiency Anemia Drug Market Size
1.5.1 Global Iron Deficiency Anemia Drug Revenue (2014-2025)
1.5.2 Global Iron Deficiency Anemia Drug Sales (2014-2025)
2 Global Iron Deficiency Anemia Drug Market Competition by Manufacturers
2.1 Global Iron Deficiency Anemia Drug Sales Market Share by Manufacturers (2014-2019)
2.2 Global Iron Deficiency Anemia Drug Revenue Market Share by Manufacturers (2014-2019)
2.3 Global Iron Deficiency Anemia Drug Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Iron Deficiency Anemia Drug Manufacturing Sites, Area Served, Product Types
2.5 Iron Deficiency Anemia Drug Market Competitive Situation and Trends
2.5.1 Iron Deficiency Anemia Drug Market Concentration Rate
2.5.2 Iron Deficiency Anemia Drug Market Share of Top 5 and Top 10 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Iron Deficiency Anemia Drug Sales by Regions (2014-2019)
3.1 Global Iron Deficiency Anemia Drug Sales Market Share by Regions
3.2 Global Iron Deficiency Anemia Drug Revenue Market Share by Regions (2014-2019)
3.3 Global Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Iron Deficiency Anemia Drug Sales
3.4.1 North America Iron Deficiency Anemia Drug Sales Growth Rate (2014-2019)
3.4.2 North America Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Iron Deficiency Anemia Drug Sales
3.5.1 Europe Iron Deficiency Anemia Drug Sales Growth Rate (2014-2019)
3.5.2 Europe Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
3.6 China Iron Deficiency Anemia Drug Sales (2014-2019)
3.6.1 China Iron Deficiency Anemia Drug Sales Growth Rate (2014-2019)
3.6.2 China Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Iron Deficiency Anemia Drug Sales (2014-2019)
3.7.1 Japan Iron Deficiency Anemia Drug Sales Growth Rate (2014-2019)
3.7.2 Japan Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
4 Global Iron Deficiency Anemia Drug Sales, Revenue, Price Trend by Types
4.1 Global Iron Deficiency Anemia Drug Sales Market Share by Types (2014-2019)
4.2 Global Iron Deficiency Anemia Drug Revenue Market Share by Types (2014-2019)
4.3 Global Iron Deficiency Anemia Drug Price by Type (2014-2019)
4.4 Global Iron Deficiency Anemia Drug Sales Growth by Type (2014-2019)
5 Global Iron Deficiency Anemia Drug Market Analysis by Applications
5.1 Global Iron Deficiency Anemia Drug Sales Market Share by Applications (2014-2019)
5.2 Global Iron Deficiency Anemia Drug Consumption Growth Rate by Applications (2014-2019)
6 Company Profiles and Key Figures in Iron Deficiency Anemia Drug Business
6.1 AMAG Pharmaceuticals, Inc
6.1.1 AMAG Pharmaceuticals, Inc Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.1.2 AMAG Pharmaceuticals, Inc Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.1.3 AMAG Pharmaceuticals, Inc Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 AMAG Pharmaceuticals, Inc Main Business and Markets Served
6.2 Meda Consumer Healthcare Inc
6.2.1 Meda Consumer Healthcare Inc Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.2.2 Meda Consumer Healthcare Inc Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.2.3 Meda Consumer Healthcare Inc Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Meda Consumer Healthcare Inc Main Business and Markets Served
6.3 American Regent, Inc
6.3.1 American Regent, Inc Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.3.2 American Regent, Inc Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.3.3 American Regent, Inc Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 American Regent, Inc Main Business and Markets Served
6.4 GSK
6.4.1 GSK Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.4.2 GSK Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.4.3 GSK Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 GSK Main Business and Markets Served
6.5 Avion Pharmaceuticals, LLC
6.5.1 Avion Pharmaceuticals, LLC Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.5.2 Avion Pharmaceuticals, LLC Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.5.3 Avion Pharmaceuticals, LLC Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Avion Pharmaceuticals, LLC Main Business and Markets Served
6.6 Bausch Health Companies Inc
6.6.1 Bausch Health Companies Inc Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.6.2 Bausch Health Companies Inc Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.6.3 Bausch Health Companies Inc Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Bausch Health Companies Inc Main Business and Markets Served
6.7 Colorado Biolabs, Inc
6.7.1 Colorado Biolabs, Inc Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.7.2 Colorado Biolabs, Inc Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.7.3 Colorado Biolabs, Inc Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Colorado Biolabs, Inc Main Business and Markets Served
6.8 Prestige Consumer Healthcare Inc
6.8.1 Prestige Consumer Healthcare Inc Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.8.2 Prestige Consumer Healthcare Inc Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.8.3 Prestige Consumer Healthcare Inc Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Prestige Consumer Healthcare Inc Main Business and Markets Served
6.9 Keryx Biopharmaceuticals, Inc
6.9.1 Keryx Biopharmaceuticals, Inc Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.9.2 Keryx Biopharmaceuticals, Inc Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.9.3 Keryx Biopharmaceuticals, Inc Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Keryx Biopharmaceuticals, Inc Main Business and Markets Served
6.10 Daiichi Sankyo, Inc.
6.10.1 Daiichi Sankyo, Inc. Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.10.2 Daiichi Sankyo, Inc. Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.10.3 Daiichi Sankyo, Inc. Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Daiichi Sankyo, Inc. Main Business and Markets Served
6.11 DSE Healthcare Solutions, LLC
6.11.1 DSE Healthcare Solutions, LLC Iron Deficiency Anemia Drug Manufacturing Sites and Area Served
6.11.2 DSE Healthcare Solutions, LLC Iron Deficiency Anemia Drug Product Introduction, Application and Specification
6.11.3 DSE Healthcare Solutions, LLC Iron Deficiency Anemia Drug Sales, Revenue, Price and Gross Margin (2014-2019)
6.11.4 DSE Healthcare Solutions, LLC Main Business and Markets Served
7 Iron Deficiency Anemia Drug Manufacturing Cost Analysis
7.1 Iron Deficiency Anemia Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Iron Deficiency Anemia Drug
7.4 Iron Deficiency Anemia Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Iron Deficiency Anemia Drug Distributors List
8.3 Iron Deficiency Anemia Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter’s Five Forces Analysis
10 Global Iron Deficiency Anemia Drug Market Forecast
10.1 Global Iron Deficiency Anemia Drug Sales, Revenue Forecast
10.1.1 Global Iron Deficiency Anemia Drug Sales Growth Rate Forecast (2019-2025)
10.1.2 Global Iron Deficiency Anemia Drug Revenue and Growth Rate Forecast (2019-2025)
10.1.3 Global Iron Deficiency Anemia Drug Price and Trend Forecast (2019-2025)
10.2 Global Iron Deficiency Anemia Drug Sales Forecast by Regions (2019-2025)
10.2.1 North America Iron Deficiency Anemia Drug Sales, Revenue Forecast (2019-2025)
10.2.2 Europe Iron Deficiency Anemia Drug Sales, Revenue Forecast (2019-2025)
10.2.3 China Iron Deficiency Anemia Drug Sales, Revenue Forecast (2019-2025)
10.2.4 Japan Iron Deficiency Anemia Drug Sales, Revenue Forecast (2019-2025)
10.3 Global Iron Deficiency Anemia Drug Sales, Revenue and Price Forecast by Type (2019-2025)
10.4 Global Iron Deficiency Anemia Drug Consumption Forecast by Application (2019-2025)
11 Research Findings and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer



★調査レポート[鉄欠乏性貧血治療薬の世界市場2019] (コード:QYR09GE06)販売に関する免責事項を必ずご確認ください。
★調査レポート[鉄欠乏性貧血治療薬の世界市場2019]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆